CLOT DISSOLVING AGENTS

CHEMICAL NAME(S) BRAND NAME
ALTEPLASE (tPA, recombinant tissue plasminogen activator) ACTIVASE
ANISTREPTLASE (anisoylated streptokinase) EMINASE
RETEPLASE (mutant tPA) RETAVASE
STREPTOKINASE KABINASE, STREPTASE
TNKase TENECTEPLASE
UROKINASE ABBOKINASE

These are also known as thrombolytic agents. They are given intravenously in the hospital to rapidly dissolve blood clots. They are used to:

The main risk with these agents is excessive bleeding.

There is some controversy among cardiologists whether an acute heart attack victim should be treated with an emergency angioplasty rather than a thrombolytic agent. There does appear to be some advantages to the emergency angioplasty but logistical problems involved in getting the angioplasty team assembled in time sometimes makes the thrombolytic agent a better option. In addition, not all hospitals have the facilities to perform angioplasty.

.RETURN TO HEART MEDICATIONS

HOME | CONTENTS | SEARCH | PRACTICE PROFILE | MEET THE PHYSICIANS | WHAT'S NEW |

CARDIAC RESOURCE | HEALTHY HEARTS | LINKS